
Calliditas Therapeutics Ab (CLTEF) Stock Competitors & Peer Comparison
See (CLTEF) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Application Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Stock Comparison
CLTEF vs SFCX Comparison June 2026
CLTEF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLTEF stands at 14.7M. In comparison, SFCX has a market cap of 17.4M. Regarding current trading prices, CLTEF is priced at $0.25, while SFCX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLTEF currently has a P/E ratio of N/A, whereas SFCX's P/E ratio is N/A. In terms of profitability, CLTEF's ROE is -0.65%, compared to SFCX's ROE of -0.15%. Regarding short-term risk, CLTEF is more volatile compared to SFCX. This indicates potentially higher risk in terms of short-term price fluctuations for CLTEF.Check SFCX's competition here